Your browser doesn't support javascript.
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
Yang, Fuxun; Yue, Ruiming; Luo, Xiaoxiu; Liu, Rongan; Huang, Xiaobo.
  • Yang F; Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu, China.
  • Yue R; Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu, China.
  • Luo X; Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu, China.
  • Liu R; Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu, China.
  • Huang X; Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu, China.
Front Pharmacol ; 11: 543718, 2020.
Article in English | MEDLINE | ID: covidwho-909333
ABSTRACT
Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Front Pharmacol Year: 2020 Document Type: Article Affiliation country: Fphar.2020.543718

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Front Pharmacol Year: 2020 Document Type: Article Affiliation country: Fphar.2020.543718